Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 2/20 | 0.38 |
| ▸ | NOS1 | P29475 | 2/20 | 0.38 |
| ▸ | NOS2 | P35228 | 2/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | BACE1 | P56817 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18630331 | 0.81 | ALDH1A1 (0.41) | ALDH1A1TERT | |
| SCHEMBL13156541 | 0.74 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL13156493 | 0.74 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL6012957 | 0.73 | TSHR (0.41) | ALDH1A1TERTCYP3A4TSHRMAPK1 | |
| SCHEMBL30587865 | 0.73 | TSHR (0.41) | ALDH1A1TERTCYP3A4TSHRMAPK1 | |
| SCHEMBL16081669 | 0.73 | TERT (0.37) | ALDH1A1TERTNOS3NOS1NOS2 | |
| SCHEMBL14599176 | 0.73 | ALDH1A1 (0.34) | ALDH1A1TERTNQO2KDM4EMAPT | |
| SCHEMBL14970138 | 0.71 | CYP1A2 (0.56) | ALDH1A1NOS3NOS1NOS2NQO2 | |
| SCHEMBL2616769 | 0.71 | CYP1A2 (0.60) | ALDH1A1NQO2KDM4EGAABACE1 | |
| SCHEMBL7992647 | 0.71 | CYP1A2 (0.56) | ALDH1A1CYP1A2UHRF1CCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-02-29 | — | — | US | disclosed |
| US-10249830-B2 | Carbazole-based compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-04-02 | — | — | US | disclosed |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-03-16 | — | — | US | disclosed |
| EP-2439204-B1 | HETEROCYCLIC COMPOUND AND HEMATOPOIETIC STEM CELL AMPLIFIER | NISSAN CHEMICAL IND LTD (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-9527828-B2 | Method for expanding hematopoietic stem cells using heterocyclic compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| US-9527828-B2 | Method for expanding hematopoietic stem cells using heterocyclic compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| EP-2218716-B1 | METHOD FOR AMPLIFYING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | NISSAN CHEMICAL IND LTD (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-9328085-B2 | Heterocyclic compounds and expansion agents for hematopoietic stem cells | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| US-9328085-B2 | Heterocyclic compounds and expansion agents for hematopoietic stem cells | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20140227780-A1 | METHOD FOR PRODUCING MEGAKARYOCYTES AND/OR PLATELETS FROM PLURIPOTENT STEM CELLS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-08-14 | — | — | US | disclosed |
| US-20100266556-A1 | METHOD FOR EXPANDING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| US-20100266556-A1 | METHOD FOR EXPANDING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2218716-A1 | METHOD FOR AMPLIFYING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2010-08-18 | — | — | EP | disclosed |
| EP-2062907-A2 | Metal coordination compound, luminescence device and display apparatus | Canon Kabushiki Kaisha (JP) | 2009-05-27 | — | — | EP | disclosed |
| US-7229753-B2 | Photothermographic material and method for forming images | FUJIFILM CORPORATION (JP) | 2007-06-12 | — | — | US | disclosed |
| US-7229753-B2 | Photothermographic material and method for forming images | FUJIFILM CORPORATION (JP) | 2007-06-12 | — | — | US | disclosed |
| US-7220495-B2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7220495-B2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2007-05-22 | — | — | US | disclosed |
| US-7205054-B2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2007-04-17 | — | — | US | disclosed |
| US-7205054-B2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2007-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10249830-B2 | Carbazole-based compound and organic light-emitting device including the same | OCIAD1, OXA1L, OCIAD2 | ALDH1A1 229/4885TERT 550/4885CYP3A4 26/4885 |
| US-20100266556-A1 | METHOD FOR EXPANDING HEMATOPOIETIC STEM CELLS USING HETEROCYCLIC COMPOUND | HCLS1, RUNX1, ACIN1 | ALDH1A1 256/4885TERT 98/4885CYP3A4 3114/4885 |
| US-20240067664-A1 | Organic Compound, Light-Emitting Device, Display Device, Electronic Device, Light-Emitting Apparatus, and Lighting Device | CCND1, CCND2, DRD1 | ALDH1A1 180/4885TERT 1369/4885CYP3A4 88/4885 |
| US-20170077419-A1 | CARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | OCIAD1, OXA1L, CYP1A1 | ALDH1A1 202/4885TERT 598/4885CYP3A4 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.